twitter twitter
Close this search box.

Building Health Equity and
Multidirectional Trust in Cancer Care

Trust Equity

A Skills- and Knowledge-Based Webinar Series

Health equity is defined as everyone having a fair and just opportunity to be as healthy as possible, an ethical and human rights principle that motivates us to eliminate health disparities. From building trusting relationships between patients and their healthcare providers, to dismantling racism that Black, Indigenous, and People of Color (BIPOC) patients and healthcare providers encounter, to overcoming the perceived lack of trustworthiness of healthcare systems, the barriers to achieving equity are high.

This 3-part, monthly webinar series focuses on building the skills and knowledge base necessary to generate and sustain trust, to reduce or remove these barriers and achieve equitable health outcomes for everyone.

Series Moderators

Mitchell Edith

Edith Mitchell, MD, MACP, FCPP, FRCP (London)

Clinical Professor of Medicine and Medical Oncology
Department of Medical Oncology Director, Center to Eliminate Cancer Disparities
Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson
116th President National Medical Association
Brigadier General (Ret.) United States Air Force
Philadelphia, Pennsylvania

Winn Robert

Robert Winn, MD

Director and Lipman Chair in Oncology
VCU Massey Cancer Center
Richmond, Virginia

Upcoming Webinars

Recordings from Previous Webinars: 2023 Series

Webinar 3: Hematologic Malignancies, With a Focus on Multiple Myeloma

Broadcast July 12, 2023

Racial differences in clinical trial participation and therapeutic outcomes

Emmitt ColeCraig

Craig Emmitt Cole, MD

Michigan State University |
Lansing, Michigan

Webinar 2:

Broadcast June 21, 2023

Breast Cancer

Unequal outcomes for Black women, what is the role of trust in eliminating disparities?

Colorectal Cancer

Rethinking risk, screening and treatment for Black patients

Dr. Laura Musselwhite’s slides were not approved for release
Newman Lisa


Weill Cornell Medicine |
New York, New York

Musselwhite Laura

Laura Musselwhite, MD, MPH

Levine Cancer Institute l
Charlotte, North Carolina

Webinar 1: Precision Medicine

Building a precision medicine pathway for Black communities to ensure equitable access and outcomes

Broadcast May 30, 2023

Slides were not approved for release.

Ahluwalia Manmeet Headshot

Manmeet Ahluwalia, MBA, FASCO

Miami Cancer Institute |
Miami, Florida

Target Audience

The target audience for this activity is community and academic medical oncologists, advanced practitioners (NP/PA/PharmD), and other healthcare providers who treat patients in the communities that are affected by inequity in the health care system, lack trust in the health care system, and treat patients with diseases and conditions that have less than optimal outcomes as a result of inequity and distrust. Physicians in the hematology and oncology space are a primary but not exclusive target audience.

Learning Objectives

After participating in the activity, participants should be better able to:

  • Evaluate the importance of trust in the clinical setting and the barriers that stand between clinicians and patients in achieving trust
  • Appraise factors that contribute to lack of trust and poor communications that lead to inequity in accessing health care and achieving optimal patient outcomes
  • Develop effective skills in communicating with diverse patients that will contribute to enhanced trust and equity in the health care system
  • Summarize how financial burdens contribute to health care inequity and develop strategies to help address and potentially overcome these burdens
  • Analyze specific diseases, malignancies, and health care issues that are affected by lack of trust and health care inequity


Joint Accreditation Statement

UNMC Joint Accreditation Logo December2020 1

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Bio Ascend.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated:

Manmeet Ahluwalia, MD, MBA, FASCO

Employee/Owner: Miami Cancer Institute at Baptist Health South Florida

Grants/Research Support: Seagen

Consultant/Advisory Board: Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen, Tocagen, Voyager Therapeutics, Viewray, Canis Lifesciences, Pyramid Biosciences, Varian Medical Systems, Cairn Therapeutics, Anheart Therapeutics, Theraguix, Menarini Ricerche, Modifi biosciences., Bugworks

Non-Mutual funds/Stock Ownership/Stock Options: Mimivax, Cytodyn, Medlnnovate Advisors LLC

Craig Emmitt Cole, MD

Discussion Board/Consultation: AbbVie, AstraZeneca, Genentech Research, GSK, Janssen, Pfizer, Sanofi

Edith Mitchell, MD, MACP, FCPP, FRCP (London)

Employee/Owner: Sidney Kimmel Cancer Center at Jefferson (Employee)

Grants/Research Support: Amgen, Bristol Myers Squibb, Genentech, Sanofi (Grant support to the institution)

Speakers’ Bureau/Honoraria for non-CME: Genentech, Ipsen

Consultant/Advisory Board: Amgen, Astellas, Bristol Myers Squibb, Genentech, Taiho

Laura Musselwhite, MD, MPH

Advisory Board: AstraZeneca

Consultant: AlphaSights, First Thought


No relevant financial relationships to disclose

Robert Winn, MD

Employee/Owner: Founding Member: Robert A. Winn Diversity in Clinical Trials Award Program established by the Bristol Myers Squibb Foundation

Grants/Research Support: Stand Up to Cancer, Merck

Consultant/Advisory Board: LUNGevity Foundation, American Cancer Society, Genentech, Phillips

The PIM planners and others have nothing to disclose. The Bio Ascend planners and others have nothing to disclose.

Method of Participation and Request for Credit

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

  • Go to
  • Login or Create a New Account (will take less than 1 minute)
    • If you receive a message when creating a new account that “the email you entered is already in use”, please click the forgot my username or password link to have your Username and Password sent to you via email
    • After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  • Type in 17386 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  • Click on the activity title when it appears
  • Choose the type of credit you desire
  • (If applicable) Complete the Post-test with a passing score of 75% or better
  • Complete the online Evaluation
  • Receive an immediate CE Certificate to download and/or print for your files

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better (if applicable) and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.

If you have questions regarding the certification of this activity, please contact PIM via email at

This activity is supported by independent educational grants from Genentech, a member of the Roche Group., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Bio Ascend Logo
PIM A 2C tag

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.